无鞭毛体
罗丹明123
利什曼原虫
罗丹明B
米尔替芬
流式细胞术
利什曼病
细胞内
生物
毒性
无菌的
分子生物学
化学
微生物学
药理学
生物化学
内脏利什曼病
免疫学
寄生虫寄主
细菌
多重耐药
万维网
计算机科学
遗传学
抗生素
光催化
催化作用
有机化学
作者
Helena Teru Takahashi,Elizandra Aparecida Britta,Renata Longhini,Tânia Ueda‐Nakamura,João Carlos Palazzo de Mello,Celso Vataru Nakamura
出处
期刊:Planta Medica
[Thieme Medical Publishers (Germany)]
日期:2013-03-01
卷期号:79 (05): 330-333
被引量:20
标识
DOI:10.1055/s-0032-1328258
摘要
Recently, our group isolated and reported the antiproliferative activity in promastigotes and axenic amastigote forms of Leishmania amazonensis treated with 5-methyl-2,2′:5′,2″-terthiophene (compound A) and 5′-methyl–[5–(4–acetoxy-1–butynyl)]–2,2′-bi-thiophene (compound B) isolated from the aerial parts of Porophyllum ruderale. Here, we demonstrated that both compounds exhibited activity against intracellular amastigotes showing IC50 values of 37 and 51 µg/mL for compounds A and B, respectively. Both compounds showed low levels of toxicity for human cells, even at the highest concentrations (hemolytic index < 10 % at 500 µg/mL). Promastigotes treated with compound A showed an alteration in the mitochondrial membrane when observed by flow cytometry through labeling with rhodamine 123 and this was confirmed by transmission electron microscopy. Alterations on morphology (rounded cells) were observed by scanning electron microscopy in parasites treated with the compounds. Further studies should be performed employing compounds A and B for the development of new drugs for chemotherapy of leishmaniasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI